Strontium Ranelate

DRUG5 trials

Sponsors

Eli Lilly and Company, Nycomed, University of Valencia, Mansoura University, Aga Khan University Hospital, Pakistan

Conditions

Clinical TrialComplianceFemur; Fracture, PertrochantericFragility FractureKnee OsteoarthritisOsteoporosisPostmenopausal Osteoporosis

Phase 4

Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial

CompletedNCT00239629

Eli Lilly and CompanyPostmenopausal Osteoporosis

Start: 2005-09-30End: 2007-01-31Target: 73Updated: 2007-06-12

Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)

CompletedNCT00479037

NycomedOsteoporosis

Start: 2007-04-30End: 2009-07-31Updated: 2012-05-08

Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis

CompletedNCT01544894

University of ValenciaCompliance, Postmenopausal Osteoporosis

Start: 2009-09-30End: 2011-10-31Updated: 2012-09-03

Role of Strontium Ranelate in Proximal Femur Fragility Fractures.

Aga Khan University Hospital, PakistanClinical Trial, Femur; Fracture, Pertrochanteric, Fragility Fracture

Start: 2021-11-01End: 2024-06-30Target: 100Updated: 2023-02-03

Unknown Phase

Strontium Ranelate and KOA

CompletedNCT03937518

Mansoura UniversityKnee Osteoarthritis

Start: 2018-07-01End: 2020-01-01Updated: 2020-05-05